Interestingly, halofuginone was also able to inhibit the ability of TGF-β to stimulate ANGPTL4 and CXCR4 expression, two factors identified as key players to prime cancer cells for metastasis respectively towards the lungs [35] and towards the bones or the lungs [36]. The gene discussed is TGFB1; the disease is cancer.